The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine.
Where this comes from
- Record sourced from PubMed, PMID 22314637.
- Also identified by DOI 10.1007/s11606-012-1988-6 and PMC identifier 3358381.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Survey data suggest that many people fear genetic discrimination by health insurers or employers. In fact, such discrimination has not yet been a significant problem. This article examines the fear and reality of genetic discrimination in the United States, describes how Congress sought to prohibit such discrimination by passing the Genetic Information Nondiscrimination Act of 2008 (GINA), and explores the implications of GINA for general internists and their institutions. It concludes that medical providers and health care institutions must be familiar with the general intent and specific terms of GINA, and should continue to collect genetic information that can contribute to the high quality provision of medical treatment. Not doing so violates their medical mission and diminishes the quality of care patients deserve.
Medical subject headings
- Genetic Privacy
- Legislation, Medical
- Precision Medicine
- Prejudice
- Public Policy